Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 122 | 41 | 39 | 40 | 35 |
| Accounts receivable | 226 | -58 | -130 | -72 | -28 |
| Other Working Capital | 414 | -278 | -4 | -65 | 40 |
| Other Operating Activity | -1,707 | -947 | -817 | -963 | -790 |
| Operating Cash Flow | $-945 | $-1,242 | $-912 | $-1,061 | $-742 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -4 | -2 | -2 | -3 |
| Purchase Of Investment | -298 | -727 | -1,641 | -715 | -2,153 |
| Sale Of Investment | 1,704 | 748 | 1,260 | 956 | 2,271 |
| Investing Cash Flow | $1,392 | $17 | $-383 | $239 | $116 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 99 | 395 | 502 | 2,653 |
| Financing Cash Flow | $0 | $99 | $395 | $502 | $2,653 |
| Beginning Cash Position | 227 | 1,346 | 2,236 | 2,513 | 486 |
| End Cash Position | 674 | 234 | 1,346 | 2,236 | 2,513 |
| Net Cash Flow | $447 | $-1,126 | $-901 | $-320 | $2,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -945 | -1,242 | -912 | -1,061 | -742 |
| Capital Expenditure | -14 | -4 | -2 | -2 | -3 |
| Free Cash Flow | -959 | -1,246 | -914 | -1,063 | -745 |